|
Aug 3
|
What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald’s and More
|
|
Aug 2
|
Trump tariffs trigger fear and loathing in ‘Viagra village’
|
|
Aug 1
|
Earnings, Fed commentary, consumer credit: What to Watch
|
|
Aug 1
|
McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week
|
|
Aug 1
|
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
|
|
Aug 1
|
Stocks to watch next week: BP, Diageo, Disney, Uber and WPP
|
|
Aug 1
|
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
|
|
Aug 1
|
3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double
|
|
Aug 1
|
Moderna's Key Patent Win Overshadowed By Gloomy Outlook
|
|
Aug 1
|
Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options
|
|
Aug 1
|
Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
|
|
Aug 1
|
Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases
|
|
Aug 1
|
Trump Demands Pharma Companies to Lower US Prices
|
|
Aug 1
|
Trump doubles down on Most Favored Nation plan to target drug prices
|
|
Jul 31
|
Pfizer (PFE) Dips More Than Broader Market: What You Should Know
|
|
Jul 31
|
Trump Talks Tough on Drug Prices but His Demands Have Softened
|
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Trump sends letters to pharma CEOs demanding they reduce drug prices in 60 days
|
|
Jul 31
|
Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs
|
|
Jul 31
|
Trump demands largest pharma companies slash US drug prices
|